Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum]
Guo Q, Chen M, Xu H, et al. Cancer Manag Res. 2020;12:1387–1396.
The authors have advised that the explanation for the #symbol is missing in Figure 2E key on page 1392. There are also missing markers for Radiotherapy to the metastatic foci and Radiofrequency ablation in the figure. The correct figure is below.
The authors apologize for these errors.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]